Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
Go back to Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance| (NASDAQ: AUTL) | Delayed: 1.51 -0.02 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.53 | 52 Week High | $ | |||
| Open | $1.55 | 52 Week Low | $ | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.51 | EPS | $ | |||
| Volume | 844,822 | |||||

